Trials / Completed
CompletedNCT02573077
An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy
A Prospective, Observational Study Measuring Sodium Improvement and Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia Secondary to SIADH in Italy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 69 (actual)
- Sponsor
- Otsuka Pharmaceutical Europe Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational, prospective, non-interventional study will include cancer patients who need a treatment for hyponatraemia secondary to SIADH. Patients will be prescribed treatment(s) according with the clinical practice regardless of the patient participation in the study. The purpose of this NIS is to collect additional scientific and clinical information that can help in describing the characteristics of cancer patients with hyponatraemia secondary to SIADH, the current management of hyponatremia, the therapies to keep under control serum \[Na+\] and the guidelines for the management of this population in Italy.
Conditions
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-12-13
- Completion
- 2017-12-13
- First posted
- 2015-10-09
- Last updated
- 2018-04-04
Locations
20 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT02573077. Inclusion in this directory is not an endorsement.